Loading...
Dermapharm Holding SE
DMPHF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$39.56
$0.00(0.00%)
Dermapharm Holding SE (DMPHF) Financial Performance & Income Statement Overview
Review Dermapharm Holding SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.000%
↑ 4.000%
Operating Income Growth
18.61%
↑ 18.61%
Net Income Growth
82.44%
↑ 82.44%
Operating Cash Flow Growth
-8.22%
↓ 8.22%
Operating Margin
17.76%
↑ 17.76%
Gross Margin
64.54%
↑ 64.54%
Net Profit Margin
8.71%
↑ 8.71%
ROE
17.42%
↑ 17.42%
ROIC
11.69%
↑ 11.69%
Dermapharm Holding SE (DMPHF) Income Statement & Financial Overview
Review Dermapharm Holding SE's (DMPHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $290.67M | $311.60M | $279.80M | $298.69M |
| Cost of Revenue | $97.49M | $115.23M | $199.19M | $188.52M |
| Gross Profit | $193.18M | $196.37M | $80.62M | $110.17M |
| Gross Profit Ratio | $0.66 | $0.63 | $0.29 | $0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $73.88M | $49.80M |
| Operating Expenses | $145.32M | $130.23M | $40.37M | $41.48M |
| Total Costs & Expenses | $242.81M | $245.46M | $239.56M | $230.001M |
| Interest Income | $2.35M | -$1.66M | $4.80M | $13.43M |
| Interest Expense | $16.51M | $17.89M | $15.47M | $15.49M |
| Depreciation & Amortization | $26.16M | $20.35M | $23.82M | $19.76M |
| EBITDA | $72.24M | $85.45M | $65.86M | $98.88M |
| EBITDA Ratio | $0.25 | $0.27 | $0.24 | $0.33 |
| Operating Income | $47.86M | $66.14M | $40.24M | $68.69M |
| Operating Income Ratio | $0.16 | $0.21 | $0.14 | $0.23 |
| Other Income/Expenses (Net) | -$13.30M | -$19.34M | -$13.45M | -$5.06M |
| Income Before Tax | $34.55M | $46.80M | $26.79M | $63.63M |
| Income Before Tax Ratio | $0.12 | $0.15 | $0.10 | $0.21 |
| Income Tax Expense | $15.50M | $14.03M | $9.95M | $20.79M |
| Net Income | $20.51M | $32.39M | $17.27M | $43.62M |
| Net Income Ratio | $0.07 | $0.10 | $0.06 | $0.15 |
| EPS | $0.38 | $0.00 | $0.32 | $0.81 |
| Diluted EPS | $0.38 | $0.00 | $0.32 | $0.81 |
| Weighted Avg Shares Outstanding | $53.84M | $0.00 | $53.96M | $53.84M |
| Weighted Avg Shares Outstanding (Diluted) | $53.84M | $0.00 | $53.96M | $53.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan